This meeting is supported by GlaxoSmithKline.

Faculty

Dr Pierre Hupperets (The Netherlands) (Chair and moderator) Dr. Christian Monnerat, MD, Prof. Michael Andersson, MD

On behalf of Prof. Carsten Rose, meeting chairman, we are pleased to invite you to the Expert Practice in Breast Cancer meeting in Amsterdam, the Netherlands on 2 February 2007. During this case-based meeting, leaders in the field discuss clinical issues encountered daily with participants in an interactive format.

Topics include:

• Overview of Her 2 family of proteins
• Endocrine therapy for a postmenopausal patient with first line metastatic breast cancer after adjuvant AI’s.
• Treating patients with multiple brainmets
• Optimal adjuvant chemotherapy for high risk pre-menopausal patients with breast cancer
• Treating patients with inflammatory BC overexpressing HER2
• Optimal adjuvant HT for postmenopausal BC (AI upfront, switch, extended adjuvant)
• Treating patients with M+ HER2+ failing herceptin
• How long do you use Herceptin – a debate

Click here for more information